Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells

Citations Over TimeTop 10% of 2015 papers

Abstract

Differentiated derivatives of human pluripotent stem cells (hPSCs) are often considered immature because they resemble foetal cells more than adult, with hPSC-derived cardiomyocytes (hPSC-CMs) being no exception. Many functional features of these cardiomyocytes, such as their cell morphology, electrophysiological characteristics, sarcomere organization and contraction force, are underdeveloped compared with adult cardiomyocytes. However, relatively little is known about how their gene expression profiles compare with the human foetal heart, in part because of the paucity of data on the human foetal heart at different stages of development. Here, we collected samples of matched ventricles and atria from human foetuses during the first and second trimester of development. This presented a rare opportunity to perform gene expression analysis on the individual chambers of the heart at various stages of development, allowing us to identify not only genes involved in the formation of the heart, but also specific genes upregulated in each of the four chambers and at different stages of development. The data showed that hPSC-CMs had a gene expression profile similar to first trimester foetal heart, but after culture in conditions shown previously to induce maturation, they cluster closer to the second trimester foetal heart samples. In summary, we demonstrate how the gene expression profiles of human foetal heart samples can be used for benchmarking hPSC-CMs and also contribute to determining their equivalent stage of development.

Related Papers

• → Two sides of the same coin? Unraveling subtle differences between human embryonic and induced pluripotent stem cells by Raman spectroscopy(2017)41 cited
• → Preparation of Mouse Embryonic Fibroblasts as Feeders for iPSC Generation and Maintenance(2020)2 cited
• The research advances on human induced pluripotent stem cells in vitro to produce red blood cells(2015)
• Abstract 20894: Therapeutic Efficacy of the Exosomes Derived From Human Induced Pluripotent Stem Cells (iPSCs) vs. Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes (iCMs) in Murine Myocardial Injury Model(2017)
• → Modeling Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells(2016)